Showing results (231-240 of 1,000) with videos related to
Sort By:
Pageof 100
Cardiovascular Therapeutics|October 8, 2026
CircIdh2 Attenuates Endothelial-to-Mesenchymal Transition and Myocardial Fibrosis and Exhibits Translational PotentialYanjia Chen, Xinai Meng, Tian Liu, et al.Cardiovascular Therapeutics|October 12, 2020
Low Ethanol Concentrations Promote Endothelial Progenitor Cell Capacity and Reparative FunctionLars Brodowski, Bianca Schröder-Heurich, Berina Kipke, et al.Cardiovascular Therapeutics|October 12, 2020
Patterns of Circadian Variation in 24-Hour Ambulatory Blood Pressure, Heart Rate, and Sympathetic Tone Correlate with Cardiovascular Disease Risk: A Cluster AnalysisMyung Han Hyun, Jun Hyuk Kang, Sunghwan Kim, et al.Cardiovascular Therapeutics|July 14, 2021
Ginkgolide B Protects Cardiomyocytes from Angiotensin II-Induced Hypertrophy via Regulation of Autophagy through SIRT1-FoxO1Qingyuan Jiang, Ming Lu, Jinyu Li, et al.Cardiovascular Therapeutics|June 11, 2021
Remote and Anesthetic-Induced Myocardial Preconditioning Is Preserved in Atherosclerotic LDL Receptor-/- Mice In VivoWalter Petermichl, Kathrin Eglmeier, Henriette Hesse, et al.Cardiovascular Therapeutics|December 21, 2022
A Study on Weight Loss Cause as per the Side Effect of LiraglutideJin Yu, Jeongmin Lee, Seung-Hwan Lee, et al.Cardiovascular Therapeutics|July 8, 2022
Effectiveness and Safety of Nonvitamin K Oral Anticoagulants Rivaroxaban and Apixaban in Patients with Venous Thromboembolism: A Meta-Analysis of Real-World StudiesOlivia Wu, Stephen Morris, Torben Bjerregaard Larsen, et al.Cardiovascular Therapeutics|July 11, 2022
Heme Oxygenase 1/Peroxisome Proliferator-Activated Receptor Gamma Pathway Protects Intimal Hyperplasia and Mitigates Arteriovenous Fistula Dysfunction by Regulating Oxidative Stress and Inflammatory ResponseTingfei Xie, Yunpeng Xu, Lecai Ji, et al.Cardiovascular Therapeutics|May 25, 2010
Therapeutic strategies in patients with chronic stable coronary artery diseaseMichael J Zellweger, Matthias E PfistererCardiovascular Therapeutics|October 27, 2010
Erythropoiesis-stimulating agents and heart failureErik Lipšic, Peter van der Meer, Dirk J van VeldhuisenPageof 100